Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06649721
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:22.871052+00:00
Published At
2025-09-02T00:00:00+00:00
Record Updated At
2025-09-02
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Drug-resistant Tuberculosis", "Pulmonary Tuberculosis", "Rifampin-resistant Tuberculosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-02"
protocolSection.identificationModule.nctId
"NCT06649721"
protocolSection.identificationModule.officialTitle
"Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis\uff1aBDLL Chinese Cohort"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Drug-resistant Tuberculosis (protocolSection.conditionsModule.conditions)
  • Pulmonary Tuberculosis (protocolSection.conditionsModule.conditions)
  • Rifampin-resistant Tuberculosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.